About Adam Davies

This author has not yet filled in any details.
So far Adam Davies has created 123 blog entries.
adam@daviesmpls.com

Makana Statement about Transplant of Gal-Knockout Pig Kidney into a Recently Deceased Human with an Intact Circulation

MIAMI (October 25, 2021) – We at Makana Therapeutics and Recombinetics would like to take this opportunity to congratulate our good friend and colleague Dr. Robert Montgomery and his team at N.Y.U. Langone for their recent breakthrough experiment transplanting a Gal-knockout pig kidney into a recently deceased human with an [...]

Makana Statement about Transplant of Gal-Knockout Pig Kidney into a Recently Deceased Human with an Intact Circulation2021-10-27T14:08:12-05:00

Makana Therapeutics Awarded KidneyX Artificial Kidney Prize for Innovation in Xenotransplantation

EAGAN, Minn., Sept. 15, 2021 /PRNewswire/ -- Makana Therapeutics today received a $650,000 KidneyX Artificial Kidney Prize for their work to increase the supply of kidney donor organs through pig-to-human xenotransplants. Xenotransplantation is the process of transplanting organs or tissues between members of different species into humans, thus addressing the [...]

Makana Therapeutics Awarded KidneyX Artificial Kidney Prize for Innovation in Xenotransplantation2021-09-21T08:40:23-05:00

First GM pigs for allergies. Could xenotransplants be next?

The FDA greenlights α-Gal allergy-safe meat, but its makers have organs for transplants in their sights. The first genetically engineered pig products could soon be coming to a dinner plate—or pharmacy—near you. Late last year, the US Food and Drug Administration (FDA) authorizeda facility in northern Iowa to raise hogs [...]

First GM pigs for allergies. Could xenotransplants be next?2021-04-19T10:46:00-05:00

Recombinetics Announces Study to Improve Outcomes for Rare Disease Patients

Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today announced a first-of-its-kind study to improve outcomes for patients diagnosed with a rare disease known as Tuberous Sclerosis Complex (TSC). Surrogen, a subsidiary of Recombinetics Inc., is focused on developing large animal models [...]

Recombinetics Announces Study to Improve Outcomes for Rare Disease Patients2020-12-01T09:14:33-06:00

Acceligen Opens Doors in Brazil

EAGAN, Minn., Oct. 14, 2020 /PRNewswire/ -- Acceligen, the leading Precision Breeding company for food animals, today announced that they are opening a new office in Aracatuba, Sao Paolo State to better meet the needs for commercialization of their traits to improve cattle, swine, and fish in Brazil.

Acceligen Opens Doors in Brazil2020-10-30T14:57:54-05:00

Precision Crossbreeding of African Dairy Production Systems

EAGAN, Minn., Sept. 24, 2020 /PRNewswire/ -- Acceligen, a Recombinetics Inc. company, today announced that it received a grant from the Bill & Melinda Gates Foundation to develop bovine genetics optimized with traits desirable to smallholder dairy farmers. The breeding program will contribute to more sustainable production by using traits [...]

Precision Crossbreeding of African Dairy Production Systems2021-09-21T08:37:48-05:00

SDPB Radio: CEO of Acceligen Talks New Grant

A grant made possible by the Bill and Melinda Gates Foundation is meant to develop bovine genetics optimized with traits desirable to smallholder dairy farmers. Acceligen, a recognized global leader in the development, deployment, and commercialization of precision animal breeding technologies. They are launching a program for precision crossbreeding of [...]

SDPB Radio: CEO of Acceligen Talks New Grant2020-10-30T14:58:44-05:00
Go to Top